Ireland· IE-PA-PA1077/044/009
Flixotide Diskus 50 micrograms, Inhalation Powder, pre-dispensed
A fluticasone product containing fluticasone propionate, registered in Ireland by GlaxoSmithKline (Ireland) Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fluticasone is registered in 16 of 19 countries.
Countries holding a registration under ATC R03BA05 (fluticasone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Fluticasone · ATC R03BA05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Fluticasone propionate
- Manufacturer
- GlaxoSmithKline (Ireland) Limited
- Country
- Ireland (IE)
- ATC code
- R03BA05
- ATC class
- Fluticasone
- Defined daily dose
- 0.6 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1077/044/009
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
576 interactions on record for fluticasone.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluticasone · interactions on record
576 records
- 35 severe
- 44 moderate
- 20 minor
- 475 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- MifepristoneG03XB01severe
- DesmopressinH01BA02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlixotide 50microgram disksGlaxoSmithKline UK Ltd
- United StatesFLOVENTA-S Medication Solutions
- FinlandFlixotide DiskusGlaxo Wellcome Oy
- BelgiumAerivio Spiromax 50 µg - 500 µgTeva
- PolandFlixotide DyskGlaxoSmithKline Trading Services Limited
- SpainAVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASALGlaxo Group Limited
- NetherlandsCortifil 0,5 mg/g crèmeLaboratorios SALVAT, S.A.
- Japanフルチカゾンフランカルボン酸エステルグラクソ・スミスクライン
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Belgium · Flixonase Aqua, Flixotide
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- France · Fixorinox, Flixonase
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Netherlands · Cortifil, Cutivate
- Norway · Avamys, Flurhin
- Poland · Cutivate, Fanipos
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a83a181d-ddea-4f6f-9322-33d35d28ba6c GET /v1/drugs/a83a181d-ddea-4f6f-9322-33d35d28ba6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalation powder, pre-dispensed",
"routes": [
"Inhalation use"
],
"source": "hpra",
"atc_all": [
"R03BA",
"R03BA05"
],
"strength": null,
"pa_number": "PA1077/044/009",
"substances": [
"Fluticasone propionate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "02/12/1996",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.